{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.0",
    "document_metadata": {
      "name": "Tau protein aggregation is associated with cellular senescence in the brain",
      "version": "1.0.0",
      "description": "",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "authors": "Sandra Spalek",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de"
    },
    "namespace_url": {
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mesh-names.belns",
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "GFAM": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/785431732a26d6809b4162d98b95687d16404e63/export/hbp.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns"
    },
    "namespace_pattern": {
      "DNSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/knowledge/hbp_knowledge/musi2018.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "dasatinib (anhydrous)",
      "id": "d7aa2eaf31f21a440ddcaaaa0632eeea66b804b9e599b4d53f5897f1dd9fca1be24adbfcd78444d7e4ecd7cf04de21e5afb6e8b01c0b33e41aa07eafe475d6db"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "quercetin",
      "id": "e4c4761d88df97c2fc11a3417fde064ff9112867d645bc4a70c06cdf4d47519af7bf121e6dd2527efcea98757fb88606b69340675c6b7e667f05449fa9577337"
    },
    {
      "function": "Abundance",
      "namespace": "GO",
      "name": "neurofibrillary tangle",
      "id": "3b50c674ff9633f408e5173562a06cf3a856abc95a8b034db8e940b464f1cea72df6f9fa9b7b02b5daf4eb86a37a155f203289451f7203a7b9c9e6c65313eadf"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00045",
      "id": "516df64cd7ee673ffb9973bac682b211d24adc9453409dd52e57dac1c773b455e5a35e37e6509f4a7f92ca2c86a505adf703d8e82c0fb37faace2c7f6573885f"
    },
    {
      "function": "Abundance",
      "namespace": "HP",
      "name": "brain",
      "id": "eea01ab1ef60d43bbb08e34f9ecf5527a441b05eaf503f0ae4f55415ad1ff08c8bb82fbfc3af0b87c6cea239127c209fb6304aaf78cd77e2c5eb0ee45539d989"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Immunotoxins",
      "id": "e15165a3029e4ac8f46ef3401e099533a405eb3ff08100b00d549a87e2ef948c78602ed783b7e9ae8f13f0adc7f1eb67feecc178c44f2a63c58b820fae50c3ea"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Mitochondria",
      "id": "8239d19592a7e8cb8a527e24faaa0525a4e648d810d9bf5a43a163754e30e3c96fb63ce1c21e2a445871a5b231d04c1852723d5b756f0b7276343cc13d48e781"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "NIK/NF-kappaB signaling",
      "id": "03697f121a26abd135ba54aa98c3b94e2b0ce3126eaeb45822a256e87ada060c314ca017fcb070d1000678dc7be8c69f0e0fe8409e8d923976c9c6d7f21f390a"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "apoptotic process",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cell cycle arrest",
      "id": "924812ea7349584b470a4985c4ce6672a686341bb8b4e1faa0d42f516fa8f28a623f24999bf62553718b59be66d102c493b3a972f4ccb0b7b541af755e35efa2"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cell cycle",
      "id": "6094aee83bf2073fe7567b4ba384def1579341a05c17348c519813bb3152436b15f8c1f9857f2cef179021a268ce84b9ebf55383c957560041f4d60a0d20bd4c"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cell death",
      "id": "b2ecb9d87645a0a7d5efbe2c9eeeaa14a705a36b6cdf787e071ba334fdd12b4caaf12b88508b99a8974005549b3c8123c9481c5d969630df072082b07e4dc586"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cellular respiration",
      "id": "9ddd1e2f8de9532f4c9e276a14aa2dbb15c257bbe5ac1b1c60dc9d758691015a32029e530fa94ebda65285da5fa8a399da7451a7e873368708276e6ec361d1e0"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cellular senescence",
      "id": "773026c747082fe2bb1dd4d7fe68db9d7321caede3d47c421791f48b892d9732d752357d28d757e63303a0eb31bf5abcba3069bf4de640a872cf7c89c7b425bd"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "inflammatory response",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "metabolic process",
      "id": "905e15ef383c0913b073f0f722670504adcca5a5a4e40af740cf54038aa57763c5b4d36fa2bec0b43ca24ad7f87e89709b7d9f95ccd729ff6c8ec3362c4c6660"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "neuron death",
      "id": "ad7c90f2bc746a5118759fd1c8857478c02207d574a26faaac9d6e4d6fa4661d8d87446139db0024a4011aae26027d3cabdfba663aec0ac0a8242868efb81dcd"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "oxidative phosphorylation",
      "id": "3bd24f678779c13e6cee554c157c9da34dbc1ccb12981c5519ef8476164c4c831743fb78ed37b3dc6ed2a41100ee39796e1af59a4f5e6129ccf265afef91a315"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "oxygen transport",
      "id": "83f131e63fffcf862ae39f07f789fd1500b307f85bbbc5479b277a0f7affee023a1b1cb9632364e96b75f5101b1f7402ea0dbff2eecf3fb417964a7dd275898a"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "tissue remodeling",
      "id": "512d55e8d751f3cbe784e935d6d40571189b6ebafb0a8e259117a6453cbb087b9b447266a0adfdd75deb8f678517b7644afc2a61c6ceb9b2b05731949ad8be71"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cognition",
      "id": "8d73f2caa1c473289d5f37cbdd4ad391a120cdbdf2356b373070c2a7b2bc0c785eaa620782fa2dd947c666100f0a169e81f35864f359cadf3e1550962fcc4127"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "HBP00037",
      "id": "1030498ceb2ae13f2056b7faab7ddafc87bfa958a8b4f2275f45d508c874310da9c097a2bfaa89632619e809898d1d0110c80eca7e58922718426199791a067c"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HP",
      "name": "Neurodegeneration",
      "id": "96f5a3bbd33a722b2760c6448efdaabb70ed3e96434c786a9ad70ca7eb89b9585204c9e8df72a4ab1b5c7f617a36f919bde50523c31467d62a4842b479ddd805"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Cell Survival",
      "id": "abeaa000ab588015eac485dd605b78602795a7e237f3b097d8148a27fa3ebcc7a221d318d0399960d9f10cf194fbc9c29f41a2a8ed8c332b09f4b79680170b61"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Cerebrovascular Circulation",
      "id": "0c6dfa5b779e621169ecdf100563233331e817c17f29fc66872af505cb454f9a525f1154b5d2b831c4c6dd2c45adc97a3bf83d6d0c5069884a6e7f799adddeca"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "DNA Breaks, Double-Stranded",
      "id": "53c4b2497c8c12ad031dec1f8219448add8e9861a78b51ebab0579ae3edb6f9e3f14d02b949498fbaae451f679f2993c259b010657e2eaa5f28e55d79da1223f"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "DNA Damage",
      "id": "9a03596d9927eb8a4251ccef96d2d7b90f365946444f031283827b33bd8c443cd0a1613473c80b7dd928e1cb94d4e34509651c8ac96ee5cefbf8b31f758c3e00"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Neuroprotection",
      "id": "4faae7cda7ea712ac9d9c27de14c6457cd84758cc7195c23f72e23fa92f07677fd6328b40deb0811b5e6fdda4375bc95095893a935493c67ad814bd89755e3b1"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "dasatinib (anhydrous)",
          "id": "d7aa2eaf31f21a440ddcaaaa0632eeea66b804b9e599b4d53f5897f1dd9fca1be24adbfcd78444d7e4ecd7cf04de21e5afb6e8b01c0b33e41aa07eafe475d6db"
        },
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "quercetin",
          "id": "e4c4761d88df97c2fc11a3417fde064ff9112867d645bc4a70c06cdf4d47519af7bf121e6dd2527efcea98757fb88606b69340675c6b7e667f05449fa9577337"
        }
      ],
      "id": "5aa4c2878783aae2c86b15b0b7b885db9b7e3bf53f9a99f1d2811c3966a960f2e1fa43db9fe4c07cf0f388798f138013ef0a2374f34de36ec7468fa8f3c78535"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDKN2A",
      "id": "cc1b5025cb68807a41b72d2559258c330d00b7b5e5c2f88db1c6a7aca25f28ac9cabb8c2cc967ba1ceabbeef7e9aba618786ea9df5b2d5faf034097e368446aa"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CXCL1",
      "id": "6a131e726acafd4d951890ba3435b92156d5654a5df283509baa5d4ff2a9ec32a267f7d4098b1e6b0f549ea48a0091588b18d4cf4c0d461d587ca8ec53fc3728"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IFNG",
      "id": "62cfdd82d4c88d6b478cc090157904f51b07aa9e32f7eba577268b9c51218959c2feee8b8c0cfdde0fda4a029c25054b81cc6765e5d8f8e204825987371903f5"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "IL1B",
      "id": "bd7736973dc00dadc09dff75214ff05344d2e9b6dfbc09a364f08b7cae84142149292551bd60d5addd6130e971c2ccd4c73b963ad918ad9b0a418b94e5a30cfd"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "NFKB1",
      "id": "74e7c9867608715faaa5f4830a18e4dc77fa067db8c026e1686035b6fcf3fad3d5c832d4ee98a6ee44f9f3733039c270ada87a1b6166034833f69653618dd386"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TLR4",
      "id": "78baff0fa37f42a32cb911fcb85a347d217c0cb39fc58b19343a2a831d87febb268c4e159670cd621d3a7e29526bc3acfb79ac387aadea33a00624d7024e6701"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TNF",
      "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Aif1",
      "id": "5d50974555db423ca2ef1177c06aec71cbad84aac5002e4204ea9fd501422bd5d0ce73be85a3f6655182f6247fdd94d3b4c050046696b50988ecf355929d942b"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Bcl2",
      "id": "95c76aab713a65425cb4b660cb287773cf8974e2db3ce6515d97be60a73ec1e856f3b2fdf321e590de58ba6b151621ef85b02500e36576ffe1d2aba2afef2394"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Cdkn1a",
      "id": "ad3a7aabfd7d4aaf57a528fb0d952ff150abc9ba67863e74ba7f3aaf3af323721712e48bd5a84f4b61380fe5008b74275664f4c09c115df7031b6b825911c5d5"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Cdkn2a",
      "id": "86190a2bc27a66eb6e4d9ca71cc870d7e962b474767712c52f32211282339c0ec01c173d0a9d53e63fd209bcd73d806e863409b8ec177cbc54977255e63091fc"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Cxcl1",
      "id": "3c9123174230ee292dacad8f1eb4ea7a9c525178ebbf543db7ead6f9c8f96b833bd5dcf1658c2cc21918eda444981ddd428420055a685dea877da31b6b856b8f"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Dlg4",
      "id": "efbd503487dcaffdd68be92d9adce7bc32d290ef6cc91492d0ec5611a041a0590e8de0025ef254be48d2550a5ca2c3439fbdc0ea8eb36b9f4fbb970ec12f8ce6"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Glb1",
      "id": "3d6977a09a96a638ed16c84f8bc2f9dcc50bdf620dfb29c62df880e69c3ee482ffc8e084045ea5aa045be942248039fa2577d2b494a056c5499b9cce45f439ac"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "H2afx",
      "id": "c4e55cf8b806f55359e891405fd629246cfac8979546a7f7a1b4c48a7e81962c3bbc49fcfabf0e8e70c0cce083129bf917e02f20983f00ef28b330e55511e34c"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Ifng",
      "id": "5f466e830fe517488aaaee8a39c28d7eb005274254ea98720fc30e6cefa1c69bcebc9d7854743ec5a3f2ff85925f990003ca2cfa4349c49eda150272471b0401"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Il1b",
      "id": "687adaa5d38b87eb816cf53120a115fe59e0725752db5823333edf76b86316cfc63ba90160f3f8c5d4e58c40863ff1dcb9e6c2c33f1e1e1fc68ecfec74c18aa4"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Jak1",
      "id": "8d4b39d212cd766a9eb8016cf934991193e2e858954f0145b1a8150390766a929e3664c2f061c007eb6619b1298a3426cb1a4b3a40c8f18085c74b488224d3b7"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mapt",
      "id": "7d94454106658b1e4190b417a419f7ccbab4b525157cd679cbb4da8a006b08c3819b0a360b692358b3f80ea2648890248be2aa7c97e1d59962dc6aa097560f2d"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mapt",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "866eb2548d3ebb8c575db22b2dbbed794da750619a04d31b30c8ffbd59b1562d89d2191f4ea30cc09874d9d44f251a203918593f4cc4e29a12eb1d52d0f58bd4"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mapt",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Pro301Leu"
        }
      ],
      "id": "cb4d9e7ada2a1bebe9b2b0560001e3ca48bac98b19a5c12e5b38e302e33c15460e501c72d6d3fb6c2e82afcbbeaf2403f0d65f6925bceedc1d78737845c147cb"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Nfkb1",
      "id": "bd873db5e5e6862601a7b692d3b86b346ab6cf369e62988abcb6c1dabc91dd6497b19fe113634e8886545c2f3fd675b8cdc4a6d58f29af2db5f49ff3d19126c5"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Rbfox3",
      "id": "e2a2e7683aafccf3698f7d77f6a36d7060f9dadaae7597d05abc7f29275299a1b11a8f2bf337afaf510cb4fced0360e4cceb358a97488c4268c3d49e4aa7a24e"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Rela",
      "id": "fb9b2c51cd7f2ce9104d48be9da59b8a51b52ac0b7098475833c53b15ccd0a69e713dd9754fdccd953826d68db80268a8dcd0c4b737d9d2c0734bf6091616dba"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Stat1",
      "id": "3f878fb37bbbda32bd2b3d249ed627d0adb3af3ce9c705cc5de41266a2fa04099ee7defc08ccb7cdec7614add3e009b61b184d783f6c2549ed2eb63f4f2ce57a"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Syp",
      "id": "81f5125d4b52aac9a857be32b63ec0cfb4206764335f8942e31d07bc0d579e8dab81cc419d387f2d6d3913d6b219d530e68d5199d0106174a91f1824a212a736"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Tlr4",
      "id": "3ed0d387c1898f210a01623e8881069555cd5a7ab7389c889536d0ba941377a7debe9b7dc290afb4645e225eb41c3bedf6b78126afaafafd605bc1500b1a39c5"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Tnf",
      "id": "a45cfec2fa122ac50a93a261bc8a06b78b1756617089bb7c55634a6f53f49a60f04f79884235d0da17620eedecf0a8422cc773f07b0dcabf7aad98cf3ebf0b72"
    },
    {
      "function": "Pathology",
      "namespace": "HP",
      "name": "Brain atrophy",
      "id": "fbd1cb1d15d0558412f177f9c0946905e5473ba3f0b23177134afe2e8fa738cd3011583b50578870daa40cd1d5616fcb84175c3709efad53fe87920cbec092eb"
    },
    {
      "function": "Pathology",
      "namespace": "HP",
      "name": "Cerebral atrophy",
      "id": "40a16f4e0370fa7002537952c6e7d953029a7edd520b14589cdf286b1241727ef76dc0daa9612baabb7a6d83355892372a94cc4557bac20d3ac418767186e81f"
    },
    {
      "function": "Pathology",
      "namespace": "HP",
      "name": "Hyperintensity of cerebral white matter on MRI",
      "id": "1536573667ee36d599c15ffe821d3ea7a5ea65d98ed168576d9cc3623cf84cc6a1743f566cf4ae42e0a15bfaeb39e01bdff6300ab12805712c18fe85ac703209"
    },
    {
      "function": "Pathology",
      "namespace": "HP",
      "name": "cardiac ventricle",
      "id": "d0589383bb66be4aaae168bb7b00ed9da182455ea32dc17265dc993e2d29c987e22a729fc86c3e598e012f208f46c3dc5e86719f8a8c52457fa5c8f94d93436b"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Brain Injuries, Traumatic",
      "id": "045bae6eea134b42537774fcd702c7450a66a9f19fedd90aed63fed01468978b1449afeb8e68a5bf609df87bb9d2bc4613280f3a7225911fb029ca78ab2f02d7"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Cerebral Small Vessel Diseases",
      "id": "404b54895cd08541e3ccafc5fdcfe353c7e839f6c0401cf53c7dd9522c4b1cf81898715ad212916776ef1922a1d31189c3861dceb6fc206570d1a36e34d0feb8"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Cognitive Dysfunction",
      "id": "bd78fa3131dd9ef6067a5fe3ee8689c946c79d0da1bedb054d1f4400b9ad0d3ae041837faa0fbacee0af5a57a4cd343d11e73fd53fd05269e3558803a56df69c"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Hypertrophy, Left Ventricular",
      "id": "71c04cc5f7cc4b6334f6a7666b9f091e90dfbd4cb226bb6f788542ebcc218ec4c0444e28a643dfbd011cb4fab67bfd1a2609b2043b955985891da37389379741"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Hypertrophy, Right Ventricular",
      "id": "0d73a09fbca2062b61a6f329f0fa721fbc1c79b202f3be066691f23bb104b9673e1b4a832d3dc39b8aef4711aee14799b5f73dcb5bdbd2c5afb4d831704f01f7"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Motor Disorders",
      "id": "de533e6c384fbd82a035846f8bacbfe0b05a1669df76ade1b87351c17ffc233fc4a2b5b33af6e10b173aa257f030e2f8527a86d5ddbc2655b306c1253498558f"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Parkinsonian Disorders",
      "id": "c8f00a1701a79f9ee3beb045eba4fcc3a424ef97eada95f64db7b1948b18340202c77d03734dfca6650ad58c3f5a81b9a824fd7a3ee805c6bfc25fb05c581ae1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Supranuclear Palsy, Progressive",
      "id": "06432576e845db5beb8ae7a4c0ae23454b691ca1773f3467bbd58f6ce3d484e768e57b6abbc21258bd43941d8ed10874fa0d45b24d91638ed7e42dcb0e5c7dd1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Dementia",
      "id": "64388ba3ecebbe4d33fb76bedff9f458276b3ae72f47d401c6852d7f9d7c2abf4b2c4cfb899133f8c6ef9f7eff00a84697a1719fa10fed2e67ec00e97d00ed65"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Gliosis",
      "id": "46d8ab84a7ce6995389ca278324930486e96f976926c8cc7fe6a9d293d79524be3010be1e4a9cb2975094b5fe03efce5bb8a536051d0ca1cb100da38c5f62c6f"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Ischemia",
      "id": "272fe4f40ba1de290325d0a55a40fb07b07a40de2058e6098c984b74e6f790bd09dc428529c06f18107b9b8dd77405b9850eb60e439a42cb491f4659dda2d747"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Necrosis",
      "id": "3c4249493f71209a37df0633ffefcd0bc33f3362df6326715550ac84989c4bb030bdd69f5e4ee27ad8fecefa8c17d55b8a7fed97320c7f0950b846b3a33cd80f"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Tauopathies",
      "id": "d2087b32a76c528191af8305652f4664cbeb31b3f4e3f9627aaf61259e271f83a7d1be65f83e9178ccf3811482ece65b940fe4ce9a714b2281f705c0d499502b"
    }
  ],
  "links": [
    {
      "line": 73,
      "relation": "association",
      "evidence": "Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI) and over twenty others",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 34,
      "target": 63,
      "key": "d022a54388a4fe2d07570659a26269e001f12ab420d85d3dd69ac2680314e33faf4a68c7054fa8a0f6513666aec86dcd7c1c2926823b85f1d560f9b06daa15e0"
    },
    {
      "line": 74,
      "relation": "association",
      "evidence": "Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI) and over twenty others",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 34,
      "target": 71,
      "key": "03cc2ad5c79f3fb9812cac21ecf0eaf7680e89acb2bb7c42eaf1f522ef701ada4e12eaac74af564eae5ec88d05352ef2f6884aba413e42d6bdf14b545a1992b9"
    },
    {
      "line": 75,
      "relation": "association",
      "evidence": "Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI) and over twenty others",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 34,
      "target": 64,
      "key": "ea54d883930f40436b7fb15e0ff5770bbb838fe3110789a0138acbf9ed6bcc0861ad064f7d8a771a9ab2c316ebcd855d9f47573f9a1a57770f8d0cb7def808d0"
    },
    {
      "line": 73,
      "relation": "association",
      "evidence": "Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI) and over twenty others",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 63,
      "target": 34,
      "key": "58fa0e404ebb99ae9566029dddee177f69a4b6caad86fa7aabb0d4fd34690b2b8c7733bbd590d30cb43017ed87599c2bf6ac57f6f1bc7828b565fd1a7592a135"
    },
    {
      "line": 372,
      "relation": "association",
      "evidence": "Aberrant cerebral blood flow is a functional defect that occurs in AD and tauNFT mice, and is closely associated with cognitive impairment (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 63,
      "target": 25,
      "key": "98826a4c897ff1994cc59c048c32c8ea6cd08b86b8ba014806385b2d422e53e2737ae9ab6d3c563d9a93e196710b29502e7d72445712092ff605bd577c459e2a"
    },
    {
      "line": 74,
      "relation": "association",
      "evidence": "Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI) and over twenty others",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 71,
      "target": 34,
      "key": "9e63a5b711daa72e07dd120139175f55aa493e47815bea22634c9d147bff1f951715bb6e7d3083120c5b84feac70ae4dd3127b608a3102f5bd11788c4211c4a6"
    },
    {
      "line": 301,
      "relation": "increases",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 4,
      "key": "d1321140f28bc8c01d1d254b81a02b1c50c8314e044016486804cd08776219138bb9be96f818021efa646e3e8fb57cef22e3f352f00efdf80851eceff6666c17"
    },
    {
      "line": 302,
      "relation": "increases",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 3,
      "key": "fb8b2d0bd50e3b21e46f8ee9e877dc13b79102ec644b48d02691fd877551d57c6b8d50d015f7a64450c12d7adb220121e82f9ef7c2d30722060caf77496c66c9"
    },
    {
      "line": 303,
      "relation": "increases",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 23,
      "key": "914862a326438073df3bf0699900a0f41b95c5cb33d31c60a31d0b614dee0e405734cb620ef6fde12722ab273044ad40a8c14559566c982b57d54b43c742cb6c"
    },
    {
      "line": 304,
      "relation": "increases",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 73,
      "key": "aa796958dcf79e84f52fa262f3b7890c16b09089d9207e7ae016df951c0d611306f39367669c4f161c8c9e68f6a30425c68036dfffffbdf5f5f2d351aefbfae7"
    },
    {
      "line": 305,
      "relation": "increases",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 69,
      "key": "eb6c20e72a0c245a7144fa26fc980e91243d3a291db5b766efba587454db1bc0ee5db844aa6da6d5f1481a81f02be167184235e186948f7d9add23dd5b590ecd"
    },
    {
      "line": 306,
      "relation": "association",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 70,
      "key": "1372527100d9ba2a3d1a1d0fa0ade4061c8edbeb54bf28399caabb58936b6797dac8a3e13fbbbccdeff3a9027941d2db5ce761a8ae086f9d474525baa57e436f"
    },
    {
      "line": 307,
      "relation": "association",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 76,
      "key": "2b8dbb57fdf42eaf9d0c0ef3eeb05ce8b4283a9b2518d47e32233014b9ae711a25012ff5782feb47b6403c2c5b96b241c34802fc54c01c25db275793af46ab60"
    },
    {
      "line": 308,
      "relation": "increases",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 66,
      "key": "3cf261b96a1940f7362b206365358aded3db8d24af06b5373c9ac4013a241de8dd4b834e322a07189a00d056a53fd300905b25344753d4cd7b6d882bab0b2a30"
    },
    {
      "line": 314,
      "relation": "positiveCorrelation",
      "evidence": "Consistent with the results from transgenic mice, CDKN2A was upregulated in PSP brains (P = 0.0415, Figure 4g) and expression correlated with NFT deposition, specifically in the parietal lobe (ANOVA, P = 0.0008; Kendall’s Tau rank correlation P = 0.059, Figure 4h)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 71,
      "target": 30,
      "key": "34949b80410c513620585556a4f0b8ea237dcc5e332dd894858f065bc6f866003059455bc07aa2ecaf9f7b9f2a55d3e799574efe1f048dde22c92bb817b9fede"
    },
    {
      "line": 75,
      "relation": "association",
      "evidence": "Tau protein accumulation is the most common pathology among degenerative brain diseases, including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), traumatic brain injury (TBI) and over twenty others",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 64,
      "target": 34,
      "key": "265b806eb9ff1c88da8a52f6106b9720fb49696eafbe208edf22b8088c03333827f5d3ea9c712584a3283e833175b96f42e0aedc1bf2149e56065e35dcd07f09"
    },
    {
      "line": 80,
      "relation": "decreases",
      "evidence": "Tau-containing neurofibrillary tangle (NFT) accumulation is the closest correlate with cognitive decline and cell loss (Arriagada et al., 1992), yet mechanisms mediating tau toxicity are poorly understood",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 3,
      "target": 21,
      "key": "396dbb0e27f57b50af8bb6cf17ab0bae1c288a329c979c741d60d9dd66941992446a214fedddcc2cb7d07953d163151274cfb10349a8bd3649f3fae08bff45c0"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "Tau-containing neurofibrillary tangle (NFT) accumulation is the closest correlate with cognitive decline and cell loss (Arriagada et al., 1992), yet mechanisms mediating tau toxicity are poorly understood",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "source": 3,
      "target": 12,
      "key": "789708555751611669dc2b71c74296cc8a519671fca5019c823f6da5b5757078e04522692c6f964a6c3c3daafbe2a540c20e1411b237ce0c9b327aa31aa8d13f"
    },
    {
      "line": 144,
      "relation": "decreases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 12,
      "key": "b3f372ec83b408226df2d91989632688e26f41d072b7e39e82fe0fc611d5857fadd0ce756585f25df5ba13dc4ef7aea515044fe9a5684472108729a08da06e90"
    },
    {
      "line": 98,
      "relation": "positiveCorrelation",
      "evidence": "Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 3,
      "target": 41,
      "key": "e9079c8ca8af0e55ffb392abfff195b8b083f37125cc8b0240d2864f32ff4b3899ed5586a9d1cc6167ad3dcfae6e6008427895f8d311825c816c9a370362093c"
    },
    {
      "line": 162,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 41,
      "key": "6cd31d4fb193445fb0480d33525eeeef863197eb56a5d4327f73710ac86e6e128ff3a611d48c83f248c89c43efd0821e5a624cbec613efa632cc7e4236ffb553"
    },
    {
      "line": 279,
      "relation": "increases",
      "evidence": "Cdkn2a gene expression increased significantly during this age interval, and at 28 months of age tauWT Cdkn2a expression was similar to that of 16-month-old tauNFT mice (Figure 4c)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 3,
      "target": 41,
      "key": "d947f3c351fd960b027e4b5fe3bc5d7c35cc536ce38227cf468e592e1f42859c1851d3b098086cba65c95d428e6f7318bcfdcb63f05351ee5daa8a4f8c11c9e8"
    },
    {
      "line": 288,
      "relation": "increases",
      "evidence": "In 15-month-old mice with heavy Abeta deposition and phosphorylated tau, but lacking NFT pathology (Orr et al., 2014), Cdkn2a expression was not elevated (Figure 4e). These data indicate that Cdkn2a expression was neither a response to general protein accumulation, nor to pre-NFT tau pathology, but instead required the presence of NFTs",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 3,
      "target": 41,
      "key": "5886c3968cb7616c2554174c481b2975f89cfaf90c3348971cf2a03e3248d88c0eb9bb4bfa6a439875ebf0a98076604497497e3c2030e4993c13c2f56210b2f4"
    },
    {
      "line": 113,
      "relation": "association",
      "evidence": "Collectively, these findings indicate a strong association between the presence of NFTs and cellular senescence in the brain, which contributes to neurodegeneration",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 3,
      "target": 14,
      "key": "32e3477e9923ed105d1304d0a3af591f1b25a25e388e60121518828e02479bda7a4b6201ab24e2eeac6041571cc1568fcb7999b5cf0881d9a284da0c36c9c90a"
    },
    {
      "line": 139,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 24,
      "key": "da1becd2c8fcbe0c3dff196d39c6f9d9ead7ca3342f3da79a65c8e22e9d3896eedc7ed569256ef58bc9e4ca3937e712e163cbc43e436221ae6851d238279f1a2"
    },
    {
      "line": 140,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 15,
      "key": "5de441441f2fe0b9cb8672cb83eeaa39ce99fa727d723dc780e02ab48a590f2871c69e15b6f9d1e40faea57362ac15e5ad679969e8082a874aaa07f1df340b0a"
    },
    {
      "line": 141,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 11,
      "key": "7ba9d9b880ddff297eba6fe51f1e3c884d5fe74f600d2010919fa74dbefef07783f0e3477978c12908d65fb517cb312772f1fcca7ec970718a93139062d3963a"
    },
    {
      "line": 142,
      "relation": "decreases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 9,
      "key": "befc1a14281e9d60cbf9016298592a4d80c83c6ef0e0bdb1566662712f7fde62f070b3397c15dd95ed35f031710b7a8fde4ee5972b90fb259fde12557b0b4201"
    },
    {
      "line": 143,
      "relation": "decreases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 75,
      "key": "98d4299ed7f5f8a3a98d0f73423808a3d082aff94bc5f48c42c191e1938cda3b0b523889a37fd98c8645ed8087901804b8169a747d4bc9e440d29dbc9abf831e"
    },
    {
      "line": 145,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 35,
      "key": "91995a1ec61784da96a18dd3fa07a02cf6b1a273c2d0a1f898f85bcede273e141217e79b77dc657d2f491326eb8bbd9af5308dc972b4df7d1a9c11aaae21d770"
    },
    {
      "line": 146,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 32,
      "key": "a645e2fc179ea4062b47c077b680f1949848a0a732b50b6bd1ff65d6e3a925c6f628c60b26eb67d6b3e06a41331f5fceeae62ce44009e2a06df95cfc4ac4cfae"
    },
    {
      "line": 147,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 37,
      "key": "0b8dfd17a373b039b3a43a000a738a12962f798623c256551d36401e969a50e0db2f9433e2254715a2ca21ed5a9f576b7fbae5a14103b997b17b44ff6dd9f005"
    },
    {
      "line": 148,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 36,
      "key": "619e7fa04bef8191e270db601e7c4288654f968760c22c23b1811f8fb5a6548b33edfb58e731164a24f5ed386e9b3e99a69ec41ffb9621e1d85220312846e153"
    },
    {
      "line": 149,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 33,
      "key": "f789f69286a112e29811bbcd4814df83808445284b7d32157d315c9b31adf9cf74b7f49c3c31f4dd05e5fd03582a9a321623ae68d807bf55db614de09968eace"
    },
    {
      "line": 150,
      "relation": "increases",
      "evidence": "NFT containing neurons upregulated genes involved in cell survival and viability, inflammation, cell cycle progression and molecular transport and downregulated apoptosis, necrosis and cell death pathways (Figure 1a). NFkB, a pro-survival master transcriptional regulator of inflammation, was the highest predicted upstream regulator of the NFT-gene expression profile. In agreement with inflammatory activation, other predicted upstream regulators included IFNG, TNF, TLR4, IL1B and CXCL1 (Figure 1b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 31,
      "key": "478ebded61e270546d1ec1c99a59aac48b45bcb4a2ef7e1453744a0b791261c985c39cf03a3264e4d89138d11ac8b84e3b1d7d687199014fa8e2f7351fde9849"
    },
    {
      "line": 157,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 46,
      "key": "797d7016e52511764797299a0ac09014274247f53eabb2b87f92a9428be40cbc95640f42a0be845936ee19e6450428422a1baa5896847dc27debf66fcf026f46"
    },
    {
      "line": 158,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 58,
      "key": "80906f065affc0d9fcaf3c8b93c23985878dea0c5723b2fcf5b2ead18279107be3e76ba3a3f030af1851de14c70029192e29280d5ac72b887cfae4e95447c712"
    },
    {
      "line": 159,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 47,
      "key": "d36a8faca2c3d82772065cb452c30d4cb30b89a9b6a488c198a720193d531d73537a2240a5e5ec240b848b25be00151eeb184fbbfc498a2d6a4105fc59591da6"
    },
    {
      "line": 160,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 48,
      "key": "6e5bb46c6447c9a0791ae141e9f2cabaf6878544e78147c13c8b4b6154c0a30d5b71b45949eb5d682a36dbea94e3e3b14d62a261dee4959fac0dd8846aaf35be"
    },
    {
      "line": 161,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 55,
      "key": "9a203e11ff1f6f4c23edfbc3fd8219b467f8949b65176c96293eeea6a1036d8596d13e96a7caaf8a823efe00370cf76f053c9b09b114c61de9a56b74f9a93735"
    },
    {
      "line": 163,
      "relation": "increases",
      "evidence": "Consistent with NFTs from human AD, mouse NFTs also caused significant activation scores for IFNG, TNF, IL-1B, as well as enrichment in other senescence associated JAK, STAT, CDKN2A and BCL2 predicted upstream regulators (Figure 1c) indicating translational relevance for using tauNFT mice to explore our hypothesis",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 3,
      "target": 39,
      "key": "7b714924af0424b7d29da614fc7fd8cdc1f71e31a6454f0b20255f9aef8576988ef1f7fc1bf4a0ce781d0486332ead300326644ff2a46c917ce1322a30d1efc7"
    },
    {
      "line": 188,
      "relation": "association",
      "evidence": "Similarly, elevated expression of the cyclin dependent kinase inhibitor 2a, Cdkn2a, is one of the most robust markers of cellular senescence, and its protein product, p16INK4A, co-localizes with NFTs in human AD (Arendt et al., 1996)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 30,
      "key": "17ae1dbae1be2bfef1eefe9b509ef5105dd8b1ac7898e2873f1fcba38791329f3c9cc2f1cb4bed31b5f22323728d56986d509b6319a3a335b7054515b4a6755e"
    },
    {
      "line": 316,
      "relation": "positiveCorrelation",
      "evidence": "Consistent with the results from transgenic mice, CDKN2A was upregulated in PSP brains (P = 0.0415, Figure 4g) and expression correlated with NFT deposition, specifically in the parietal lobe (ANOVA, P = 0.0008; Kendall’s Tau rank correlation P = 0.059, Figure 4h)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 3,
      "target": 30,
      "key": "2fef9e0b33688b37753c4ce973d6ee4dc7b6721329e75d46713c1fbcce55b73025d40219f19b335099728152a22dfe7a83b64d0c0635b913586feee35886b888"
    },
    {
      "line": 322,
      "relation": "increases",
      "evidence": "Collectively, these findings led us to conclude that NFTs were directly linked to senescence-associated Cdkn2a upregulation, which in turn was a strong predictor of neurodegeneration and cognitive decline",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 3,
      "target": 30,
      "key": "b13ab86f09c4c54247bfc48153e7c54e2563735bb2debc06b582ac846347d90de181bcbddfc158539953612e7544f9d76293a7dd26d4ce1165a0f34fb997d4ba"
    },
    {
      "line": 246,
      "relation": "decreases",
      "evidence": "We found a significant genotype main effect for oxygen flux in both cortex and hippocampus, indicating that global respiratory capacity was impaired in NFT containing brain regions (P < 0.0001; Figure 3), an effect primarily driven by CI+CII respiration coupled to ATP production (cortex: P = 0.0034; hippocampus: P = 0.0215; Figure 2g and h, respectively), and uncoupled or maximum respiratory capacity (cortex: P = 0.0248; hippocampus: P = 0.0261; Figure 3g and h, respectively)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 3,
      "target": 19,
      "key": "4991c02e3174aa6090918a584af41f58d207e39a2fc2b759883ca857c8c3759e620d66b7b2fc148a3573fb49686a82d0bef94dd1c584ab8f212febcbb975db19"
    },
    {
      "line": 342,
      "relation": "association",
      "evidence": "NFTs are highly correlated with the rate of ventricular enlargement, an indicator of brain atrophy and hallmark of AD pathology (Silbert et al., 2003)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 68,
      "key": "4ee9c98323c95c4b2dcd60eca83496e64e7e340685f1af1e7e78fe95753f1ae635d7cb9cdd1ec38a75a08993b97b84057c6e249f0db52437eff4f39f80c7ca62"
    },
    {
      "line": 343,
      "relation": "association",
      "evidence": "NFTs are highly correlated with the rate of ventricular enlargement, an indicator of brain atrophy and hallmark of AD pathology (Silbert et al., 2003)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 67,
      "key": "b3ec5ab967df0ab830fb36809bc4f6d1d1e13f8af333d7292b9eb8ac792fc21b051851142ead250a0e00ab3038bf05e6f118614670c06168ed8f44e38ee01bc8"
    },
    {
      "line": 344,
      "relation": "association",
      "evidence": "NFTs are highly correlated with the rate of ventricular enlargement, an indicator of brain atrophy and hallmark of AD pathology (Silbert et al., 2003)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 3,
      "target": 59,
      "key": "02a34918226cd97361adb54d0c9ccc7b76144928661a05966a5c352b9d1e9b0bcf6e44eb06542ce14d96ea9a5c2b785930699664a09b5f4d486469522bda5343"
    },
    {
      "line": 88,
      "relation": "association",
      "evidence": "Transcriptomic analyses of NFT-containing neurons microdissected from postmortem AD brain revealed an expression profile consistent with cellular senescence. This complex stress response induces aberrant cell cycle activity, adaptations to maintain survival, cellular remodeling, and metabolic dysfunction",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 11,
      "key": "f4e51c42a2a52eb8a052743dec4c21765de5ff0d70e5f218f5011a7b8386ec5a6aeebff777600a29e24450ff3c0548390cb4309dccc090f04775b327b5fc62c4"
    },
    {
      "line": 89,
      "relation": "increases",
      "evidence": "Transcriptomic analyses of NFT-containing neurons microdissected from postmortem AD brain revealed an expression profile consistent with cellular senescence. This complex stress response induces aberrant cell cycle activity, adaptations to maintain survival, cellular remodeling, and metabolic dysfunction",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 24,
      "key": "8778614eb10e6cdf7fb088b07e13a32077a2053a0abce2f122df659da21901def319d65953f745e8a78977e97e483d091725786a021e61a1bccc54cdf94aeffc"
    },
    {
      "line": 126,
      "relation": "increases",
      "evidence": "This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction and disruption to surrounding tissue to the secretion of toxic molecules (Childs et al., 2016)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 24,
      "key": "26864a0a0cbce9c7fd9db472fee0b17f7ba7dc88339a29fafcc98c20bd6a4f63ab742baa7d4615389b24ada791e209e37a5dd56b6647f26e3333e6297447ae70"
    },
    {
      "line": 217,
      "relation": "association",
      "evidence": "NFkB regulates the pro-survival, pro-inflammatory SASP gene expression profile characteristic of cellular senescence (Salminen & Kaarniranta, 2011)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 24,
      "key": "1db5c824309fd81323b0ceb9e106cb7d2158c7f60d892a2b4ccfe44cdf2a47ca58273534f80c31426c1280a89be0bfa34f6ba9752c8c71674b6e4dbe4d378317"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "Transcriptomic analyses of NFT-containing neurons microdissected from postmortem AD brain revealed an expression profile consistent with cellular senescence. This complex stress response induces aberrant cell cycle activity, adaptations to maintain survival, cellular remodeling, and metabolic dysfunction",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 20,
      "key": "0871682c553bde407f5ed695dcd173c7abc4c3358ea279a22367282d0ccffa8ea55a4b6112fa2b519efaeb8a662586b53da1447928704591be367289e1eef5db"
    },
    {
      "line": 127,
      "relation": "increases",
      "evidence": "This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction and disruption to surrounding tissue to the secretion of toxic molecules (Childs et al., 2016)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 20,
      "key": "19493607ba1990cd933c6dd83401baf6369ec463d3d51cd14c3fd382c7b55703a0b338c0d20a8a6f04376732a909bd2b9d86f8c60244542aef9aa2572ce15e48"
    },
    {
      "line": 91,
      "relation": "decreases",
      "evidence": "Transcriptomic analyses of NFT-containing neurons microdissected from postmortem AD brain revealed an expression profile consistent with cellular senescence. This complex stress response induces aberrant cell cycle activity, adaptations to maintain survival, cellular remodeling, and metabolic dysfunction",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 16,
      "key": "e638069e21599d89a08a371700b9eae81ae8ba62b495edcc6052f175e8498831928e6c99aa7f964b7f00da77f07c3f5c836c41c9f4f5927abcae294978f88ca4"
    },
    {
      "line": 128,
      "relation": "decreases",
      "evidence": "This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction and disruption to surrounding tissue to the secretion of toxic molecules (Childs et al., 2016)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 16,
      "key": "8e9d2e93bdc42eb4a1374661bc9c70df4f663b7b9cdae9363d32066ea463cb1939f1c9ddb23422c3b7b2fbb0d69f3b19e3080817819c7154f4f8d5ab6f7b9eee"
    },
    {
      "line": 96,
      "relation": "association",
      "evidence": "Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 41,
      "key": "236026e8ac743f4406e5d05996df112b3b3d577eacd7a6883d24cba87cb2210b0bc90c0ba7e9a2123ea2ff651d794ca3aea21f296839a6206bf4e836a76873f4"
    },
    {
      "line": 104,
      "relation": "increases",
      "evidence": "Tau transgenic mice with late stage pathology were treated with senolytics to remove senescent cells. Despite the advanced age and disease progression, MRI brain imaging and histopathological analyses indicated a reduction in total NFT density, neuron loss and ventricular enlargement",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 3,
      "key": "df057da7a1044a500c080c847f95985394289c290f6b031a4e8e698498676705ea314c1cff0eb4c4cfd6777652d26a3276462c07863a338e7eb804f1b0b46048"
    },
    {
      "line": 113,
      "relation": "association",
      "evidence": "Collectively, these findings indicate a strong association between the presence of NFTs and cellular senescence in the brain, which contributes to neurodegeneration",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 3,
      "key": "3b14d30948aeac5c59d79f1dbe9b0ddd06fcc9f02dd885cba6215147afbaf8205ffbb4b6fef79c4447299c5d7c3fa3ff5610cd7ecb06ee405eafc21a95ce92c1"
    },
    {
      "line": 105,
      "relation": "increases",
      "evidence": "Tau transgenic mice with late stage pathology were treated with senolytics to remove senescent cells. Despite the advanced age and disease progression, MRI brain imaging and histopathological analyses indicated a reduction in total NFT density, neuron loss and ventricular enlargement",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 17,
      "key": "570fa4dacc0a389c4b85cbedc8c00b5dba68ee3a69be84b88e97132b341efc8588ee2ddbd3d314017278b26946f3f86fcf68484b65afb8cfb0ef30feb7d4d667"
    },
    {
      "line": 106,
      "relation": "increases",
      "evidence": "Tau transgenic mice with late stage pathology were treated with senolytics to remove senescent cells. Despite the advanced age and disease progression, MRI brain imaging and histopathological analyses indicated a reduction in total NFT density, neuron loss and ventricular enlargement",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 68,
      "key": "3f79c05a874100cf885d12a40df49c41c9a0c1c1a30056c0050b2dba9f2ee0c20c1907bad776f38dac5ad542bd5958fd69d23986b4d0c6ddce4f18b2c7455c4e"
    },
    {
      "line": 107,
      "relation": "increases",
      "evidence": "Tau transgenic mice with late stage pathology were treated with senolytics to remove senescent cells. Despite the advanced age and disease progression, MRI brain imaging and histopathological analyses indicated a reduction in total NFT density, neuron loss and ventricular enlargement",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 14,
      "target": 67,
      "key": "26d23c3c14775b4fefb5e1de05b0a8b30769fa47449e634c256efc4d8aca6cae292782ef71947e8d5da4961ee82a5a1c3d40a46872547c5a0901aabd0e452a1a"
    },
    {
      "line": 114,
      "relation": "increases",
      "evidence": "Collectively, these findings indicate a strong association between the presence of NFTs and cellular senescence in the brain, which contributes to neurodegeneration",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 23,
      "key": "9a91749853bdd4ab7b486616c036d61cc967e4ea27a81b7699be060396544d0fa3dce7730859c784f6010181ea5cad2b78ca880509e8c2c8131eebcf002c1150"
    },
    {
      "line": 119,
      "relation": "association",
      "evidence": "Experimental data from various studies indicate that tau pathology may be associated with cellular senescence, a fundamental aging mechanism shown to contribute to several chronic diseases (recent review Kirkland and Tchkonia, 2017)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 76,
      "key": "e20f4e6cfae41a2ca7d5bb66253dd3e098ab3dd207bbead8d17e8ada8059c6741af335f9c7725d0bbd2aeb3ccb55bb7fac44165a7e1b5f25cd04c1ed0d286fec"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction and disruption to surrounding tissue to the secretion of toxic molecules (Childs et al., 2016)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 14,
      "target": 10,
      "key": "ea8cf17b63ed80e4f740ea696eef2ec5d187b2c7270d17183875fea6eb3178f8d69da6ea67c323266dbfa1f8fb2bce6e570e973c23636f670db7f5ea6b9ef69a"
    },
    {
      "line": 129,
      "relation": "decreases",
      "evidence": "This complex stress response induces a near permanent cell cycle arrest, adaptations to maintain survival, cellular remodeling, metabolic dysfunction and disruption to surrounding tissue to the secretion of toxic molecules (Childs et al., 2016)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GOCC",
            "name": "intracellular"
          },
          "toLoc": {
            "namespace": "GOCC",
            "name": "extracellular space"
          }
        }
      },
      "source": 14,
      "target": 6,
      "key": "841d6caa2a85727d27380cd9f67e8601b24109221b4c37f3128a4e245c541222778b888075f49fcae5ed986334d231654cb4fa76a2f22f31f24896f0f6676617"
    },
    {
      "line": 167,
      "relation": "increases",
      "evidence": "Senescence-inducing stressors often inflict DNA-damage that drives production of the SASP (Rodier et al., 2009)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 27,
      "key": "ecd4484b276b20986a17a34cc5118e4c439251189e0e56088106d85ae1a7bfb808a9562204a24068b39554a787ee4f0bc0f85d3e24aa9b6051fbf911cba68155"
    },
    {
      "line": 180,
      "relation": "association",
      "evidence": "The cell cycle protein p21, encoded by Cdkn1a, is upregulated in many senescent cell types and has been associated with DNA damage during neuronal aging (Jurk et al., 2012)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 27,
      "key": "b86c9579ca243f73a334140ca2e4ddb6d005aeb317348a2a71f2ab0ce667e1b21ca1b66ba3ab2bbee31b21e88f69cf036a6f1c7176f2c31e19af972c868e43f6"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "The cell cycle protein p21, encoded by Cdkn1a, is upregulated in many senescent cell types and has been associated with DNA damage during neuronal aging (Jurk et al., 2012)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 40,
      "key": "9cf42c400368d6853ef990e69d3661b8abdc7b34487b354b4f2744ddaeac46b95bce2b5cfc7044196f5f58b6ab480a98706ac9272e0eee850271219e5901ed8c"
    },
    {
      "line": 187,
      "relation": "increases",
      "evidence": "Similarly, elevated expression of the cyclin dependent kinase inhibitor 2a, Cdkn2a, is one of the most robust markers of cellular senescence, and its protein product, p16INK4A, co-localizes with NFTs in human AD (Arendt et al., 1996)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 30,
      "key": "4f1398305d92e1c92ab1585ce22f70f91ab67a01d1b5920c7f61757a503d26c61f34277d3cec223122dd28f272333689cd2c4d63ded104142b9b1eacd990d703"
    },
    {
      "line": 216,
      "relation": "association",
      "evidence": "NFkB regulates the pro-survival, pro-inflammatory SASP gene expression profile characteristic of cellular senescence (Salminen & Kaarniranta, 2011)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 15,
      "key": "7654a0dd74ecd6992de00baebe3056861edb55011f5f06239979743b73954a3dfdc7960eaa88d33931779e44f492e89983a9580c117d1c6d5558fa37f652ed1a"
    },
    {
      "line": 237,
      "relation": "increases",
      "evidence": "Mitochondrial dysfunction is obligatory for SASP production and cellular senescence (Correia-Melo et al., 2016; Hutter et al., 2004)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 14,
      "target": 22,
      "key": "7755ad2f6d17b30b548875fcd83c7470b8536cc469ac77d406e86c36ce83bf392b9e7e9a8928cc670f79c9bdc955e7b3e6d12932383d33371b52f43b6cccf565"
    },
    {
      "line": 88,
      "relation": "association",
      "evidence": "Transcriptomic analyses of NFT-containing neurons microdissected from postmortem AD brain revealed an expression profile consistent with cellular senescence. This complex stress response induces aberrant cell cycle activity, adaptations to maintain survival, cellular remodeling, and metabolic dysfunction",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 11,
      "target": 14,
      "key": "e4d234ee9a7adc1b54e1cd74d9e29e1f6f95ecd2f7473f6989d065aa97b83eaafba2d54df8da5c444e81b1a5dfe38f979aa955a2a2c31034c48856eb2d02bdae"
    },
    {
      "line": 217,
      "relation": "association",
      "evidence": "NFkB regulates the pro-survival, pro-inflammatory SASP gene expression profile characteristic of cellular senescence (Salminen & Kaarniranta, 2011)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 24,
      "target": 14,
      "key": "5d499e92773fb4c1aca026f731d40fea28dee577ef69d631a1e09c18b1cd76f9ad6af37fce08df3c79b1ff8bad08acc6322eaab8a5e976a965cd6ddbfa5b70c2"
    },
    {
      "line": 96,
      "relation": "association",
      "evidence": "Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 41,
      "target": 14,
      "key": "9f5cd28f955a0a71c6b4d66f444a3be67421741d9acad27b2187ce017cabc42fbf33b8563d56e7ca5df703b1babb9731d79bf3a4d4c7551e61a04c47bcaf10f5"
    },
    {
      "line": 97,
      "relation": "positiveCorrelation",
      "evidence": "Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 41,
      "target": 60,
      "key": "6848ad3d09f64f815177261b40c9c5968920d92ad5c7364af1cefec9463ff1d094e0cf43e494d0d6be33370cd6c001827f150a8d2b583705febdb48c6b8709da"
    },
    {
      "line": 98,
      "relation": "positiveCorrelation",
      "evidence": "Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 41,
      "target": 3,
      "key": "3475d22982abb74a7119a8c63657bc16520f146b294d9a197c1b3ef328e7ea91baa477b33da2bf234cd0f584a0773e9610b15e903ad782c71f17198bbb4f5324"
    },
    {
      "line": 293,
      "relation": "positiveCorrelation",
      "evidence": "Further, when plotted against brain weight, Cdkn2a expression was a strong predictor of brain atrophy across mouse lines (P < 0.0001, R2 = 0.5615; Figure 4f)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 41,
      "target": 59,
      "key": "01ff9d39954e6bc0414a70b79c933d2defb91ffb342ca7f7289ecf30bd19f55601962bd69753b3218c5e38d4f3f8025444e6cb48f88f7b25f847bdb72549cd56"
    },
    {
      "line": 97,
      "relation": "positiveCorrelation",
      "evidence": "Cdkn2a transcript level, a hallmark measure of senescence, directly correlated with brain atrophy and NFT burden in mice",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "source": 60,
      "target": 41,
      "key": "2df82196339bebf0cc40a32622ccc889f1a1b4fa77838aff989bd35a3e08ac6c5b3e9d5f1572947bf87454113edebcd2248a9a2235fd2bac7b2facb0edb85e08"
    },
    {
      "line": 342,
      "relation": "association",
      "evidence": "NFTs are highly correlated with the rate of ventricular enlargement, an indicator of brain atrophy and hallmark of AD pathology (Silbert et al., 2003)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 68,
      "target": 3,
      "key": "2bfe350532d94287c7c0fb20b7656d393e6dfcd5657d34f30b5a14fd8ca2a3116c52c05ded2ffdfe8dc2a89586827ba2444469b1432dc3e451f545a179550573"
    },
    {
      "line": 343,
      "relation": "association",
      "evidence": "NFTs are highly correlated with the rate of ventricular enlargement, an indicator of brain atrophy and hallmark of AD pathology (Silbert et al., 2003)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 67,
      "target": 3,
      "key": "b4b16c3dbf80ecdb938299f79e717b922b4a48d5bdb771ba4715d22e6017115c60b3034e459e38055719eac81ffc4fc0162180050bb2e127453ba5365639e946"
    },
    {
      "line": 323,
      "relation": "association",
      "evidence": "Collectively, these findings led us to conclude that NFTs were directly linked to senescence-associated Cdkn2a upregulation, which in turn was a strong predictor of neurodegeneration and cognitive decline",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 23,
      "target": 30,
      "key": "151c648e134bb9d28b425bc01c2bea3b077fb9bbdae282a6c55063fbfbf04e27830ca1708a7758830cae1d89c4ef5eca41d26fc812c022fd00d42a28b7b19009"
    },
    {
      "line": 119,
      "relation": "association",
      "evidence": "Experimental data from various studies indicate that tau pathology may be associated with cellular senescence, a fundamental aging mechanism shown to contribute to several chronic diseases (recent review Kirkland and Tchkonia, 2017)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 76,
      "target": 14,
      "key": "481e3b652e4c8ccc85ea60947c60c803b3dd49c71734046fc1df664e8ac87b2c160c42f6dd057e6c9f968fd76090c42e3372c589acabacb3b01da033ea66c550"
    },
    {
      "line": 307,
      "relation": "association",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 76,
      "target": 71,
      "key": "f3d7117b96356b8a71c2b9fa6f9bee4f6bdc516f2cc09bb8739b7e556174db871cf4d48ecdf5535d7aaabfbf9e37fba1340520adf1318e7efda066ce0d557f2e"
    },
    {
      "line": 216,
      "relation": "association",
      "evidence": "NFkB regulates the pro-survival, pro-inflammatory SASP gene expression profile characteristic of cellular senescence (Salminen & Kaarniranta, 2011)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 15,
      "target": 14,
      "key": "c77b0151e504fa1a6030ed202a312a97e96b5e67fa2b265864267883dcf8ee04babfff4329c522ff7ed4b9d947ee0ae06af51931fa6f4874f25959556ed5f784"
    },
    {
      "line": 180,
      "relation": "association",
      "evidence": "The cell cycle protein p21, encoded by Cdkn1a, is upregulated in many senescent cell types and has been associated with DNA damage during neuronal aging (Jurk et al., 2012)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 27,
      "target": 14,
      "key": "b681e194e8240691547da0a6977ddb3e9687dc783fe13163bc3a91acedca45163456f07719dd29cfeb364c0ae65d353b462a344cb6419ae1d043e05bb2eb0b73"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "TauNFT mouse brains displayed significantly elevated histone γ-H2ax, a sensitive marker of both double-stranded DNA breaks and cellular senescence (Sedelnikova et al., 2004) (P = 0.0056; Figure 1d-e)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 45,
      "key": "4a85414004c58532fc79e22e724b09df3d77714358e1dff5ab145a07d942a818338c05c19dc07eba14009eaf7fb192950d560d8a1c67391d0efbd3006ecaa271"
    },
    {
      "line": 193,
      "relation": "increases",
      "evidence": "TauNFT brains expressed 3-fold higher Cdkn1a than control mice (P = 0.0178, Figure 1f), which was replicated in a separate mouse cohort (P = 0.0086, Figure S1f)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 40,
      "key": "5a5757d6f4196b6809ea89a0b6d499c55063c592043e5b3a29e6caf128203e66baeb8180996501b0205a4399447b1f066101a4737428c9d3184cf6d9b20f2071"
    },
    {
      "line": 199,
      "relation": "increases",
      "evidence": "Moreover, Cdkn2a was expressed at levels 2.7- and 2.6-fold higher in tauNFT than CTL and tauWT, respectively (P = 0.0303 and P = 0.0352, respectively; Figure 1g); this effect was replicated in an independent mouse cohort (P = 0.0016, Figure S1g)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 41,
      "key": "1d50e7b1705a79df9f57932bdae0b6e2ee856908535e05701271ab8f5edd19005b010bd6f75fa548bafac9c66317bf3c03886ac1f251f4fe9c554aa8d2ed45df"
    },
    {
      "line": 206,
      "relation": "increases",
      "evidence": "Consistent with the transcriptomic profile in human NFT-bearing neurons and mouse brain tissue (Figure 1a-c), SASP genes were found to be upregulated in tauNFT brains, i.e., Il1b was 4- and 2-fold higher than CTL and tauWT, respectively; and Cxcl1 was 4-fold higher than both control genotypes; Tnfa was 13- and 8-fold higher than CTL and tauWT, respectively; Tlr4 was 3-fold higher than both control genotypes (Figure 2a-d)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 47,
      "key": "e61e0ac9ab496644675e83a000fc7e139a09ab0c724d03841a2c3af440e98ab4cdea9240bc31d5d0e044a8fa9294966115b52cf2f2dce81a65178273402cf6a0"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "Consistent with the transcriptomic profile in human NFT-bearing neurons and mouse brain tissue (Figure 1a-c), SASP genes were found to be upregulated in tauNFT brains, i.e., Il1b was 4- and 2-fold higher than CTL and tauWT, respectively; and Cxcl1 was 4-fold higher than both control genotypes; Tnfa was 13- and 8-fold higher than CTL and tauWT, respectively; Tlr4 was 3-fold higher than both control genotypes (Figure 2a-d)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 42,
      "key": "ac8b0ac767167fb22bfb8fbb4b6cbbbddcce8d535847d6937c1a9761c1b93c412b533ef4bfd8972e276a508fc9e130b1279b12977cefabe304aa807b0e65bf8d"
    },
    {
      "line": 208,
      "relation": "increases",
      "evidence": "Consistent with the transcriptomic profile in human NFT-bearing neurons and mouse brain tissue (Figure 1a-c), SASP genes were found to be upregulated in tauNFT brains, i.e., Il1b was 4- and 2-fold higher than CTL and tauWT, respectively; and Cxcl1 was 4-fold higher than both control genotypes; Tnfa was 13- and 8-fold higher than CTL and tauWT, respectively; Tlr4 was 3-fold higher than both control genotypes (Figure 2a-d)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 58,
      "key": "8ab3805c7e39aec3f7379e0a890729e93b1ccdbb6764012c526b65abed3e12732195146f17d966bf7c372e3cda49b82657073e6f5c748da7f4c02b5c4d16cdb0"
    },
    {
      "line": 209,
      "relation": "increases",
      "evidence": "Consistent with the transcriptomic profile in human NFT-bearing neurons and mouse brain tissue (Figure 1a-c), SASP genes were found to be upregulated in tauNFT brains, i.e., Il1b was 4- and 2-fold higher than CTL and tauWT, respectively; and Cxcl1 was 4-fold higher than both control genotypes; Tnfa was 13- and 8-fold higher than CTL and tauWT, respectively; Tlr4 was 3-fold higher than both control genotypes (Figure 2a-d)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 57,
      "key": "cd4a2dd09c0d5f7c56d7e757ce4e858bdb29cecd3e9012638e79594cf052d7f622f6912083d037ea307e400013edce9664a0ef8ccabec904a5bb379808c04491"
    },
    {
      "line": 222,
      "relation": "increases",
      "evidence": "Consistent with NFkB pathway activation and the SASP profile, nuclear localized NFkB p65 was significantly increased in tauNFT brains (Figure 2e-f)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 8,
      "key": "cf0dc3206aeb8a74ce170be516caf3fcfe97a8f94e176a03ac7dfb15ccc5ec67a21c8263297172a2a12d5f3282fd01e0c2cbfbf1692f2306416850eb8f25bd10"
    },
    {
      "line": 223,
      "relation": "increases",
      "evidence": "Consistent with NFkB pathway activation and the SASP profile, nuclear localized NFkB p65 was significantly increased in tauNFT brains (Figure 2e-f)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 54,
      "key": "fbbbdae9e7f6c6c1fa6e276aa28ad995a4c93a01d5506096263465fb869618202bd741affde497dcb8abd021e2c6bdd8fa6397a9e307e421cd29387a3a2913d9"
    },
    {
      "line": 228,
      "relation": "increases",
      "evidence": "Examination of the gene that codes for the hydrolase enzyme, galactosidase beta  1 (Glb1), revealed that tauNFT mice expressed higher Glb1 gene expression than controls (Figure S3)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 44,
      "key": "226a2ac8ff0ef50a72811ba9dbca6ba25c770807cc8b2668b7854fedacd9f1173958d84b580b1e0f7a26c9d28cc98ba3027937db36d106ed07762df6cf65037e"
    },
    {
      "line": 272,
      "relation": "increases",
      "evidence": "TauNFT mice develop aggressive tauopathy with NFT formation in early life, and show a senescence-associated transcriptomic profile with NFT onset (Figure 1c)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 51,
      "target": 76,
      "key": "05a02fc1063dd545aa4e8970885c17bb151cf1a699f178a56eaa9af2355309e34e7783d2292229875220e9d4a2375105fa0919bc37636448a1362bb7bbe79d7d"
    },
    {
      "line": 273,
      "relation": "increases",
      "evidence": "TauNFT mice develop aggressive tauopathy with NFT formation in early life, and show a senescence-associated transcriptomic profile with NFT onset (Figure 1c)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 51,
      "target": 3,
      "key": "acba2baf8807c2b5ad69c930cbd52b30b0f1e699b32d77d4b2a02933a9fbac8c93c3bf2a124020a4e2c754af3cf9b49b3f6ff76bc2a6c27946c5aba137bf80f1"
    },
    {
      "line": 274,
      "relation": "increases",
      "evidence": "TauNFT mice develop aggressive tauopathy with NFT formation in early life, and show a senescence-associated transcriptomic profile with NFT onset (Figure 1c)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 51,
      "target": 14,
      "key": "9f94379a9a10d05fd96a26ecc8e81f31e337cd379c09c33bcd365ccf392e4085983de6b68dc144d4010c064ab0a9435b4b9c0d63db660459cf9a6b15250e6d8b"
    },
    {
      "line": 371,
      "relation": "association",
      "evidence": "Aberrant cerebral blood flow is a functional defect that occurs in AD and tauNFT mice, and is closely associated with cognitive impairment (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 51,
      "target": 25,
      "key": "a6c5d1ee0e66d54c6f0604ea9073ae4d2a3299c7684098d45a805897cb56f8a5eeac828d09ad47d2f8e498b1cab138dd88846b89fe25e27dd8398c70dd6d21b4"
    },
    {
      "line": 381,
      "relation": "increases",
      "evidence": "In brain tissue with tau pathology, cerebral blood flow was elevated in tauNFT Mapt0/0 vehicle-treated mice (21% whole brain, P = 0.045; cortex, 48.7%, P = 0.051, Figure S5d, e), and consistent with previous reports of tauNFT mice on a Mapt+/+ background (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Tauopathies": true
        }
      },
      "source": 51,
      "target": 25,
      "key": "b69b9a96fbb397c11e98552d2c2540c642120575fd3006b5fc697b5b380fd5cc1685d75aa37f8c74f8c9510d872480f0b598e0b775bce5c9ba6caffc696567a3"
    },
    {
      "relation": "hasVariant",
      "source": 49,
      "target": 51,
      "key": "005b6520ce1e0a48f9009be3ab51928177d8bfc7c3da2f691d32fd557d4a5c88f6e34a6827912f7f52a935039f1130620df5710bf51112c31d185d1002cc4de1"
    },
    {
      "line": 258,
      "relation": "increases",
      "evidence": "However, genetically ablating endogenous mouse tau (microtubule associated protein tau, Mapt) reduces NFT pathology and neurodegeneration in tauNFT mice (tauNFT-Mapt0/0) (Wegmann et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 49,
      "target": 3,
      "key": "1c02b63153ca4be18d77db4f3747fa61f221eac885d6164e2cade2011d1a6329bdbed38c2210fd10089bc70f3164d2e43f91199bf83bf2a9114ec383693a1285"
    },
    {
      "line": 259,
      "relation": "increases",
      "evidence": "However, genetically ablating endogenous mouse tau (microtubule associated protein tau, Mapt) reduces NFT pathology and neurodegeneration in tauNFT mice (tauNFT-Mapt0/0) (Wegmann et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 49,
      "target": 23,
      "key": "05b58ba8d26b1e394de5342b4b8e6c22a1340fc2ef793bf7da49bd828012e3cc4e89e05f8192d1d585f6aba432ed108359ba946eb7675b1942f3a42e8c7fbb31"
    },
    {
      "line": 265,
      "relation": "increases",
      "evidence": "The reduced tau pathology corresponded with 60% lower Cdkn2a expression (P = 0.0041, Figure 4a), decreased SASP (Figure S4) and decreased brain atrophy (tauNFT-Mapt0/0: 0.4058 ± 0.009 versus age-matched tauNFT Maptwt/wt: 0.3451 ± 0.0116; 17.5% difference, P = 0.0143, Figure 4b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 49,
      "target": 41,
      "key": "e76df8ead2f57f9979f1689b81e8403b70678ca932051cfb07223bd749be8d5cb39bc20cc20d198759851570ad175b09eeeaa9c4b072388cc243df20a05f157b"
    },
    {
      "line": 266,
      "relation": "increases",
      "evidence": "The reduced tau pathology corresponded with 60% lower Cdkn2a expression (P = 0.0041, Figure 4a), decreased SASP (Figure S4) and decreased brain atrophy (tauNFT-Mapt0/0: 0.4058 ± 0.009 versus age-matched tauNFT Maptwt/wt: 0.3451 ± 0.0116; 17.5% difference, P = 0.0143, Figure 4b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 49,
      "target": 14,
      "key": "f89f9d533759c0783c71909ff6ebec1f1bb91dffcc9f11430e9f5daf43adf7411910c894753aaaec82a8940e07730157ad3b94d90f36611ab1e00f934cb1f9fe"
    },
    {
      "line": 267,
      "relation": "increases",
      "evidence": "The reduced tau pathology corresponded with 60% lower Cdkn2a expression (P = 0.0041, Figure 4a), decreased SASP (Figure S4) and decreased brain atrophy (tauNFT-Mapt0/0: 0.4058 ± 0.009 versus age-matched tauNFT Maptwt/wt: 0.3451 ± 0.0116; 17.5% difference, P = 0.0143, Figure 4b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 49,
      "target": 59,
      "key": "d6d97d6be854e81530085f5558161ede00b94ffe8084a18620fe275c9aaa89c478650d50480e9ebd109514b098fa9f9520d684e3cc1f3c34a8924ee0486014cb"
    },
    {
      "relation": "hasVariant",
      "source": 49,
      "target": 50,
      "key": "2c2ea9b1bf222f9bdc74a04eea4aea1ce45cab18586adb11e8c9889ab3c25edcd3db437e123224f5555bba399383b0c940ffbabee03881d8e5f45b8c2605a862"
    },
    {
      "line": 173,
      "relation": "biomarkerFor",
      "evidence": "TauNFT mouse brains displayed significantly elevated histone γ-H2ax, a sensitive marker of both double-stranded DNA breaks and cellular senescence (Sedelnikova et al., 2004) (P = 0.0056; Figure 1d-e)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 45,
      "target": 26,
      "key": "cc35b03349283a0c584524319ea75805c8dea57976e99d965f93f697799b202fa407a15379301afd0f06c1f557ed91cdb6aecdea0da088da0904b242d3edbd2e"
    },
    {
      "line": 174,
      "relation": "biomarkerFor",
      "evidence": "TauNFT mouse brains displayed significantly elevated histone γ-H2ax, a sensitive marker of both double-stranded DNA breaks and cellular senescence (Sedelnikova et al., 2004) (P = 0.0056; Figure 1d-e)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 45,
      "target": 14,
      "key": "8afd1e7a604a90605b0ebbbf41ce4e138f3473902e823eda351e14833fbe4f249f4ecabb35d8795920dd582c0f308a683a68213df78d921881fd353e56e72152"
    },
    {
      "line": 188,
      "relation": "association",
      "evidence": "Similarly, elevated expression of the cyclin dependent kinase inhibitor 2a, Cdkn2a, is one of the most robust markers of cellular senescence, and its protein product, p16INK4A, co-localizes with NFTs in human AD (Arendt et al., 1996)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 30,
      "target": 3,
      "key": "66f497b0c4e1bbcc504ad61cc30abf696764c8c7781ca701d8206b167dbae61e2af560eb10ee0c840e6a8779cf06de394cb8887d124b4d50ac165133ae2cfb94"
    },
    {
      "line": 316,
      "relation": "positiveCorrelation",
      "evidence": "Consistent with the results from transgenic mice, CDKN2A was upregulated in PSP brains (P = 0.0415, Figure 4g) and expression correlated with NFT deposition, specifically in the parietal lobe (ANOVA, P = 0.0008; Kendall’s Tau rank correlation P = 0.059, Figure 4h)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 30,
      "target": 3,
      "key": "57aab8762d19562ec2fc2397b4029412dbb52170d5fea08e9e1442b90a57bef7f45d84aea281276545cbe0047b1b54609fa7d5f4bd77184f436cdca21025d97b"
    },
    {
      "line": 314,
      "relation": "positiveCorrelation",
      "evidence": "Consistent with the results from transgenic mice, CDKN2A was upregulated in PSP brains (P = 0.0415, Figure 4g) and expression correlated with NFT deposition, specifically in the parietal lobe (ANOVA, P = 0.0008; Kendall’s Tau rank correlation P = 0.059, Figure 4h)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 30,
      "target": 71,
      "key": "3eab284003a6465102e7af102e7ca00009fb75cd068a1002e631725082d41cc10098577aef732ccd4f23363fb09720266585e2c82dceb9a64e2126c4406ee90b"
    },
    {
      "line": 323,
      "relation": "association",
      "evidence": "Collectively, these findings led us to conclude that NFTs were directly linked to senescence-associated Cdkn2a upregulation, which in turn was a strong predictor of neurodegeneration and cognitive decline",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 30,
      "target": 23,
      "key": "b7f9222a02ed31b197760ae66b626cf7083ce1fe579b9fe4893b08d2f2f631813556d58f5a8fac63605c062451677799ff62fea7056c228e6711f8b8d9d07b72"
    },
    {
      "line": 324,
      "relation": "association",
      "evidence": "Collectively, these findings led us to conclude that NFTs were directly linked to senescence-associated Cdkn2a upregulation, which in turn was a strong predictor of neurodegeneration and cognitive decline",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 30,
      "target": 66,
      "key": "d1bc3cceabcb1eb0fdb77da6d59781df337f13659d2df04eb1c278b8f5c4e5ae98ce79a1a308d3d415dc857c283dc8e2ecd8744630c0679e0805acf01e956442"
    },
    {
      "line": 214,
      "relation": "increases",
      "evidence": "NFkB regulates the pro-survival, pro-inflammatory SASP gene expression profile characteristic of cellular senescence (Salminen & Kaarniranta, 2011)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 52,
      "target": 24,
      "key": "8ae1fe4e41e1ce0487225a0b576d6452dba51b5e99709862cc892dbeeefb5b6bb83e988b52f8351ec46624a49bcebb22433502631e9e10c707e47b86a97c343e"
    },
    {
      "line": 215,
      "relation": "increases",
      "evidence": "NFkB regulates the pro-survival, pro-inflammatory SASP gene expression profile characteristic of cellular senescence (Salminen & Kaarniranta, 2011)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 52,
      "target": 15,
      "key": "a5c183891df0a8ef55b32e0f477e1474e530e552f9b4607819405f9e134a60c830a7147dd161e6fc05eecfa523db84cb9e0dcf4bcbb2cb01af041a53e4da491b"
    },
    {
      "line": 233,
      "relation": "positiveCorrelation",
      "evidence": "Further, SA beta-gal reactive cells were observed even in very young mice (1-month-old) and the number of SA beta-gal reactive cells was positively correlated with brain mass (R2: 0.4852, P = 0.0039 Figure S3)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 44,
      "target": 5,
      "key": "5fc215657199b7bf6c8065801c68991e0784b00feafddb4b724f3a93ec462b9e9b48a3db8b107d1cb3b7c85394e5d77cdc1b3fd47b34297c136a4ad37abad91e"
    },
    {
      "line": 233,
      "relation": "positiveCorrelation",
      "evidence": "Further, SA beta-gal reactive cells were observed even in very young mice (1-month-old) and the number of SA beta-gal reactive cells was positively correlated with brain mass (R2: 0.4852, P = 0.0039 Figure S3)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 5,
      "target": 44,
      "key": "b3cd514385bc4d7f68be807095ede19599a36940bcbb0054ac7987993506f8259d82eac580e2a69b2cf186b41d0de1e0800fe64a6491ae0e5df1a06ed3152c13"
    },
    {
      "line": 247,
      "relation": "decreases",
      "evidence": "We found a significant genotype main effect for oxygen flux in both cortex and hippocampus, indicating that global respiratory capacity was impaired in NFT containing brain regions (P < 0.0001; Figure 3), an effect primarily driven by CI+CII respiration coupled to ATP production (cortex: P = 0.0034; hippocampus: P = 0.0215; Figure 2g and h, respectively), and uncoupled or maximum respiratory capacity (cortex: P = 0.0248; hippocampus: P = 0.0261; Figure 3g and h, respectively)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 18,
      "target": 19,
      "key": "fb39ee9dc7864ff86f8873dd5962f46280de50dcb8bb5b1042617c35fc7b36f6e7c6e064bed70282d4c49c3214ca8f747b193ee3b7b1fd6a2677f131f3bc2d69"
    },
    {
      "line": 253,
      "relation": "association",
      "evidence": "Citrate synthase activity is a surrogate marker of total mitochondrial content/mass, and was similar across genotypes and brain regions (Figure 3i) suggesting that the defects in cellular respiration were due to altered mitochondrial quality, not content/mass",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 13,
      "target": 7,
      "key": "b68295acabc6d0292aa612b4703614124f9e2833d79232f079fa93e69caa99b959a61dcd6b360ad5ab0a049b0f2c618c5387f6bdeaecfb27392797aba406943b"
    },
    {
      "line": 253,
      "relation": "association",
      "evidence": "Citrate synthase activity is a surrogate marker of total mitochondrial content/mass, and was similar across genotypes and brain regions (Figure 3i) suggesting that the defects in cellular respiration were due to altered mitochondrial quality, not content/mass",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 13,
      "key": "fa834e66fc68a2169cc9cb2cbc63ca96466a2c603bd24552698cc474cec364b8c26d7fc06782b17d0ce2330baf6064c5117eebfcbf603f8731a07320df68aece"
    },
    {
      "line": 293,
      "relation": "positiveCorrelation",
      "evidence": "Further, when plotted against brain weight, Cdkn2a expression was a strong predictor of brain atrophy across mouse lines (P < 0.0001, R2 = 0.5615; Figure 4f)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 59,
      "target": 41,
      "key": "076af7814b218b75eafc3a353d52741d3718932d9130907471c9dad9862b4c681c057ee0c59ea8ce7e4ca4786d5d81782e66723d154711f705c2f9a8c7812b0c"
    },
    {
      "line": 344,
      "relation": "association",
      "evidence": "NFTs are highly correlated with the rate of ventricular enlargement, an indicator of brain atrophy and hallmark of AD pathology (Silbert et al., 2003)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 59,
      "target": 3,
      "key": "713f649610faa20140223956c5d984a9e2626cd840f1f5f3e2c991cb545310accf084f11bb8bb512f899b4b5b4d7fb439c0ce65bba263b52ca327a68dad2677b"
    },
    {
      "line": 286,
      "relation": "causesNoChange",
      "evidence": "In 15-month-old mice with heavy Abeta deposition and phosphorylated tau, but lacking NFT pathology (Orr et al., 2014), Cdkn2a expression was not elevated (Figure 4e). These data indicate that Cdkn2a expression was neither a response to general protein accumulation, nor to pre-NFT tau pathology, but instead required the presence of NFTs",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 0,
      "target": 41,
      "key": "52384d2311bdff7984a8e1fbd54a2283e82a84acf8262e62955de01224e680983db4de47d9e3e999bc7771d498a730ec1c0248e678ea8ea6acee09491d859b75"
    },
    {
      "line": 287,
      "relation": "causesNoChange",
      "evidence": "In 15-month-old mice with heavy Abeta deposition and phosphorylated tau, but lacking NFT pathology (Orr et al., 2014), Cdkn2a expression was not elevated (Figure 4e). These data indicate that Cdkn2a expression was neither a response to general protein accumulation, nor to pre-NFT tau pathology, but instead required the presence of NFTs",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 50,
      "target": 41,
      "key": "53f775839793b82154241acd932bf458688886dcb18b007fe4a4c7ef67578501a6d2d7c8c43a4830194304ed1d897a07a354f84d9dc025723651019f34cda756"
    },
    {
      "line": 306,
      "relation": "association",
      "evidence": "PSP is an age-associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017), and is neuropathologically defined by accumulation of four-repeat (4R) tau, NFTs, gliosis and neurodegeneration (Flament et al., 1991)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true,
          "Cerebral Cortex": true
        }
      },
      "source": 70,
      "target": 71,
      "key": "ebc155cd6a77b23b20b05647aef74563b53728e1bd8175ee22db99e6fb24143fd9df5b264415ac095321d3bdac31b9cff05203107ed0165e38922b4c267e1670"
    },
    {
      "line": 324,
      "relation": "association",
      "evidence": "Collectively, these findings led us to conclude that NFTs were directly linked to senescence-associated Cdkn2a upregulation, which in turn was a strong predictor of neurodegeneration and cognitive decline",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHDisease": {
          "Supranuclear Palsy, Progressive": true
        },
        "MeSHAnatomy": {
          "Parietal Lobe": true
        }
      },
      "source": 66,
      "target": 30,
      "key": "9211d3d9012fe0ebf214dac9cfa9105702aadacf67f42edb74c03ca3443ccd21664b5e95291865e2d9ee9b161622585d02b21881bda275363d96ddc7b3f5d2b2"
    },
    {
      "line": 373,
      "relation": "association",
      "evidence": "Aberrant cerebral blood flow is a functional defect that occurs in AD and tauNFT mice, and is closely associated with cognitive impairment (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 66,
      "target": 25,
      "key": "a58e33fa911c88b6646eb63ee2869e080e9172af2679c2aff258e16b3be636fc96e1398f28e2e1bdcfae73814775973258daf483136032d6f0b8e25013bfd488"
    },
    {
      "relation": "hasComponent",
      "source": 29,
      "target": 1,
      "key": "6b73dd466849fcc13d168ca2347a40ddd12fbbe1755f8306178f00634568fbacc1b74a974b2e6c4afacf1f99372bb2540ca3c85385eda4b4429bf9a37f1dde41"
    },
    {
      "relation": "hasComponent",
      "source": 29,
      "target": 2,
      "key": "a6b92c6ea2294becabd373b3f565f9b6a004da6f45d52e765823fcbd9c3bd323dfd75dc1d2f81f57672de119f33a1a08771677b7dafbea8e887b2aa332f53248"
    },
    {
      "line": 332,
      "relation": "decreases",
      "evidence": "Consistent with senescent cell removal, intermittent DQ treatment significantly reduced the number of NFT-containing cortical neurons (P < 0.0001, 5% reduction; Figure 5a,b)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 3,
      "key": "9036e415c6759d2bfdf812813a79e6f845637fe692a77f8b82b8c589da84a9122ddbe468a626ceda5960b03b76c5a996073de525b3979677d1143a0d4d83677f"
    },
    {
      "line": 350,
      "relation": "decreases",
      "evidence": "The DQ-dependent reduction in cortical NFTs corresponded with decreased ventricular volume pathology (28% decrease, P = 0.05, Figure 5d, f) and a reduction in cortical brain atrophy (compared to controls: P = 0.0092 and P = 0.0274, vehicle and DQ, respectively; Figure S5a)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 3,
      "key": "4110b54f14e223355cbff5503dc278aedd77d72da56ff780989e56d518b850098d03bc3a49c30185c6270ecc8562c7885537b2a4a06f45fff79c40add1d3b39f"
    },
    {
      "line": 406,
      "relation": "decreases",
      "evidence": "The astrocyte protein GFAP was unchanged, while microglia Iba1 expression was elevated (Iba1: 40%, P = 0.0013; Figure S6b-d) suggesting that DQ-mediated neuroprotection and decreased SASP was not derived from a reduction in pro-inflammatory glia (astrocytes or microglia) but instead associated with fewer NFT-containing neurons",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 3,
      "key": "52ec23342b89bc3a062939d94203def1f4b821e7ce7f043e894cc31d5253dc663fca2e9d775a99d66d6a83c56cd859303dea8f9e8a236882c111984b50823bc5"
    },
    {
      "line": 337,
      "relation": "decreases",
      "evidence": "Relative to the existing neuronal population at this advanced age, gene expression of the NFT-associated senescence gene array was reduced by DQ (P = 0.0006; Figure S6a)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 14,
      "key": "f18a377743d1c3f7300922a1e7e5f871dd9c54dbc2d546d7a7c10e29b0171b3af48ef981b5a827a02138798462b1696b84524c0db7a40d7e7b1f086b7630b21e"
    },
    {
      "line": 405,
      "relation": "decreases",
      "evidence": "The astrocyte protein GFAP was unchanged, while microglia Iba1 expression was elevated (Iba1: 40%, P = 0.0013; Figure S6b-d) suggesting that DQ-mediated neuroprotection and decreased SASP was not derived from a reduction in pro-inflammatory glia (astrocytes or microglia) but instead associated with fewer NFT-containing neurons",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 14,
      "key": "1b47dea13b7cabd839a6193e02b5dccad977e20c27fa1dad26b58229eb5185cf55ef0d3a539208b53b8d3d24ae006d37a9a2d7cd6403a940a6f9b8b108763fd3"
    },
    {
      "line": 351,
      "relation": "decreases",
      "evidence": "The DQ-dependent reduction in cortical NFTs corresponded with decreased ventricular volume pathology (28% decrease, P = 0.05, Figure 5d, f) and a reduction in cortical brain atrophy (compared to controls: P = 0.0092 and P = 0.0274, vehicle and DQ, respectively; Figure S5a)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 59,
      "key": "c4c97cbbef5d090ef749f1ddae9adc61ae739b133f1bb8b77aac82ca2ecce3ceb9d2a67c845df27cb1b1b0e4568dfb61fb416d79c3094191cd440d3d2c2f6736"
    },
    {
      "line": 352,
      "relation": "decreases",
      "evidence": "The DQ-dependent reduction in cortical NFTs corresponded with decreased ventricular volume pathology (28% decrease, P = 0.05, Figure 5d, f) and a reduction in cortical brain atrophy (compared to controls: P = 0.0092 and P = 0.0274, vehicle and DQ, respectively; Figure S5a)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 62,
      "key": "8414b86a8c9b8bfba916a06c031879887760bea8b8a3b04485b114b4a552650fd32401c49a922da758ac19f0e07858484e07050d6f76ed1938caf9f4c9c8b579"
    },
    {
      "line": 366,
      "relation": "decreases",
      "evidence": "However, tauNFT-Mapt0/0 mice treated with DQ did not display WMH volumes statistically different than control mice (P = 0.2458; Figure S5b, c)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 61,
      "key": "18b4df754dd022a8c8f31fe6f50d1b88d84735633e7065720c490e651df8444508e5d849a3c3cceebdd6ca2a70ee09b949d21337394c3703969153badb8c1126"
    },
    {
      "line": 386,
      "relation": "decreases",
      "evidence": "DQ improved cerebral blood flow in tauNFT Mapt0/0 mice such that cerebral blood flow was no longer statistically different from controls (Figure S5d, e)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Tauopathies": true
        }
      },
      "source": 29,
      "target": 25,
      "key": "122fedddd79d298e51921aca71fcb298e0d308ffbf612e0db6fb214b5cd1270aeeb767d83c1bf1a45427dad12570c4acd9dfb46d3c927c12e9326dc5ed8b0c07"
    },
    {
      "line": 394,
      "relation": "increases",
      "evidence": "DQ-treated mice expressed significantly higher levels of neuronal proteins (NeuN: 25%, synaptophysin: 40.8%; PSD95: 38.5%; P < 0.05; Figure 5f-i)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 56,
      "key": "8bc00396f21941a4f957a7f11208b929c4dec1dad534a476c5e562a79edf4b3b87b5dc9f52482d0491d94c6c7eb48c546a1d50abb08ae74c62c7dbfbe52a06e1"
    },
    {
      "line": 395,
      "relation": "increases",
      "evidence": "DQ-treated mice expressed significantly higher levels of neuronal proteins (NeuN: 25%, synaptophysin: 40.8%; PSD95: 38.5%; P < 0.05; Figure 5f-i)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 53,
      "key": "1b55cc5ad4db8200b727b98b2f18b8a6f8916268271e824baf146103be2b673f9d53180847c3ae0f033d63a6ce358d01e371f8b6a4a176b9d0416bf9cf336a47"
    },
    {
      "line": 396,
      "relation": "increases",
      "evidence": "DQ-treated mice expressed significantly higher levels of neuronal proteins (NeuN: 25%, synaptophysin: 40.8%; PSD95: 38.5%; P < 0.05; Figure 5f-i)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 43,
      "key": "0432a472e3c6ea59154152cc0cebff77350e2036b6ae270bed590ba53d6a069823ceb38373bb518139f646f8aef3c732bd34702252bb0be1b7b64f74d13f049a"
    },
    {
      "line": 403,
      "relation": "increases",
      "evidence": "The astrocyte protein GFAP was unchanged, while microglia Iba1 expression was elevated (Iba1: 40%, P = 0.0013; Figure S6b-d) suggesting that DQ-mediated neuroprotection and decreased SASP was not derived from a reduction in pro-inflammatory glia (astrocytes or microglia) but instead associated with fewer NFT-containing neurons",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 38,
      "key": "a2b17c17aaf0aa5d2328ce47043ed7edf690a680a7c673eca1d987080c366472a8dbef2268a6d5e9e43a019ea5251d746cc8322945dcd44846adeee58ad8f8a4"
    },
    {
      "line": 404,
      "relation": "increases",
      "evidence": "The astrocyte protein GFAP was unchanged, while microglia Iba1 expression was elevated (Iba1: 40%, P = 0.0013; Figure S6b-d) suggesting that DQ-mediated neuroprotection and decreased SASP was not derived from a reduction in pro-inflammatory glia (astrocytes or microglia) but instead associated with fewer NFT-containing neurons",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 29,
      "target": 28,
      "key": "204856c4496940a6d07401840b0f6b6d98da348195e0d331deb71b8ab334b2a7b270c7bedaf72f74608fc2628a84c43f9621ea7e6790df6836eaab712eec7971"
    },
    {
      "line": 358,
      "relation": "increases",
      "evidence": "WMH is driven by cerebral small vessel disease, which causes chronic ischemia and increased risk of cognitive decline and dementia (reviewed, (Prins & Scheltens, 2015))",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 65,
      "target": 61,
      "key": "8e37f7b485a3cb85c98c18868357ca29a3407cc0d21fa45eaaff6a6c503f4351880e5b239de78c7d4ecff5e4014c1f5cdc1945f5542f8a2160aa4c9ad83686d2"
    },
    {
      "line": 359,
      "relation": "increases",
      "evidence": "WMH is driven by cerebral small vessel disease, which causes chronic ischemia and increased risk of cognitive decline and dementia (reviewed, (Prins & Scheltens, 2015))",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 65,
      "target": 74,
      "key": "3a74be520c0dd38cad81a11d2aeb37ff24a831b24cee251764631b1e75fc93e88849d8c7cd4f45f08b46319c67ff18e80b88080db5c99d9fc395d3035d9588ed"
    },
    {
      "line": 360,
      "relation": "increases",
      "evidence": "WMH is driven by cerebral small vessel disease, which causes chronic ischemia and increased risk of cognitive decline and dementia (reviewed, (Prins & Scheltens, 2015))",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 65,
      "target": 66,
      "key": "e4a2b8a59fecd749583caf840f336db38563785117f7ff16030ec57ac4ccc2a03be991601e6165867a0b1dc64b74b0e65fd280a370f3da0dac4515b179ebf3b0"
    },
    {
      "line": 361,
      "relation": "increases",
      "evidence": "WMH is driven by cerebral small vessel disease, which causes chronic ischemia and increased risk of cognitive decline and dementia (reviewed, (Prins & Scheltens, 2015))",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 65,
      "target": 72,
      "key": "d592bbb15070381d29c58e9c808b0bfdf3537aa9f5bd873f58bb3f6d725b79aa504129367e0efe80dea558847ccb3688eb18f1c543e8f60e86628491e173fada"
    },
    {
      "line": 371,
      "relation": "association",
      "evidence": "Aberrant cerebral blood flow is a functional defect that occurs in AD and tauNFT mice, and is closely associated with cognitive impairment (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 25,
      "target": 51,
      "key": "d37123f7f8af3e21596c291b8f9779e68c03a82c268f4913e11b9f600f59bab006c44d039f29f8c88f75d8bf238a499a72d803a174efbcbfd0e1ac9b578ff884"
    },
    {
      "line": 372,
      "relation": "association",
      "evidence": "Aberrant cerebral blood flow is a functional defect that occurs in AD and tauNFT mice, and is closely associated with cognitive impairment (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 25,
      "target": 63,
      "key": "7346110dc9eb2e88df253d89debc6210eba6201fe4f050450180e28567d390f92f7cdcefcf722ebc9e976570fd38f98764ee2c014bdf10059a16e77f682fc17d"
    },
    {
      "line": 373,
      "relation": "association",
      "evidence": "Aberrant cerebral blood flow is a functional defect that occurs in AD and tauNFT mice, and is closely associated with cognitive impairment (Wells et al., 2015)",
      "citation": {
        "type": "PubMed",
        "reference": "30126037"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "source": 25,
      "target": 66,
      "key": "2314e041d765e9a200eaa5d3f17e7e8bbd2f822f31bd7354efe14cf776f662f213618f05d5988e071dcbd64a53c09fb9686dd97fbb66cadb2bf49d596f084f78"
    }
  ]
}